MedTrace Logo

Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction

NCT01593566 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-04-09

No results posted yet for this study

Summary

Femoral nerve block using 0.25% bupivacaine or 0.5% bupivacaine provides a longer time for analgesia after Anterior Cruciate Ligament (ACL) reconstruction.

Conditions

  • Analgesia After ACL Reconstruction

Interventions

DRUG

0.25% Bupivacaine

Femoral nerve block using 0.25% versus 0.5% bupivacaine

DRUG

0.5% Bupivacaine

Femoral nerve block using 0.25% versus 0.5% bupivacaine for analgesia after ACL reconstruction

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • arissara iamaroon · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-04-30
Completion
2013-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01593566 on ClinicalTrials.gov